farnesol and Muscular Dystrophy

farnesol has been researched along with Muscular Dystrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aga-Mizrachi, S; Brunschwig, Z; Chapman, J; Dadush, O; Elad-Sfadia, G; Elbaz, M; Elmakayes, E; Ettinger, K; Haklai, R; Kloog, Y; Nevo, Y; Reif, S; Yanay, N	1

Other Studies

1 other study(ies) available for farnesol and Muscular Dystrophy

Article	Year
The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy. PloS one, 2011, Mar-22, Volume: 6, Issue:3 Topics: Animals; Base Sequence; Blotting, Western; Disease Models, Animal; DNA Primers; Farnesol; Fibrosis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Muscle Strength; Muscular Dystrophies; ras Proteins; Salicylates	2011

Article

Year

The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy.

PloS one, 2011, Mar-22, Volume: 6, Issue:3

Topics: Animals; Base Sequence; Blotting, Western; Disease Models, Animal; DNA Primers; Farnesol; Fibrosis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Muscle Strength; Muscular Dystrophies; ras Proteins; Salicylates

2011